Dominguez Wealth Management Solutions’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$727K Buy
2,887
+2
+0.1% +$430 0.4% 38
2026
Q1
$628K Buy
2,885
+2
+0.1% +$444 0.38% 42
2025
Q4
$659K Sell
2,883
-8
-0.3% -$1.82K 0.4% 41
2025
Q3
$669K Buy
2,891
+37
+1% +$7.54K 0.42% 38
2025
Q2
$530K Buy
2,854
+2
+0.1% +$372 0.37% 46
2025
Q1
$598K Buy
2,852
+2
+0.1% +$389 0.44% 41
2024
Q4
$506K Buy
2,850
+2
+0.1% +$368 0.37% 46
2024
Q3
$562K Buy
2,848
+2
+0.1% +$373 0.41% 44
2024
Q2
$488K Buy
2,846
+15
+0.5% +$2.48K 0.37% 46
2024
Q1
$516K Buy
2,831
+2
+0.1% +$345 0.41% 44
2023
Q4
$438K Sell
2,829
-14
-0.5% -$2.04K 0.36% 46
2023
Q3
$424K Sell
2,843
-26
-0.9% -$3.82K 0.39% 44
2023
Q2
$387K Buy
2,869
+2
+0.1% +$293 0.34% 44
2023
Q1
$457K Buy
2,867
+2
+0.1% +$306 0.42% 41
2022
Q4
$463K Buy
+2,865
New +$439K 0.46% 37

Other funds holding ABBV

Dominguez Wealth Management Solutions's ABBV Position: Q2 2026 in Review

Dominguez Wealth Management Solutions increased its AbbVie (ABBV) stake by 0.07% in Q2 2026, buying an estimated $430 and bringing the position to 2,887 shares worth $727K. The position accounts for 0.4% of the portfolio, ranked #38.

Dominguez Wealth Management Solutions first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Dominguez Wealth Management Solutions held 2,887 shares of AbbVie worth $727K as of Q2 2026.
  • Dominguez Wealth Management Solutions bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.4% of Dominguez Wealth Management Solutions's portfolio in Q2 2026, its #38 holding.
  • Dominguez Wealth Management Solutions first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Dominguez Wealth Management Solutions's 13F filing for Q2 2026, filed 9 Jul 2026.